Breaking News Instant updates and real-time market news.

GHDX

Genomic Health

$52.13

0.99 (1.94%)

04:55
06/18/19
06/18
04:55
06/18/19
04:55

Genomic Health management to meet with Piper Jaffray

Meeting to be held in San Francisco, CA on June 18 hosted by Piper Jaffray.

  • 18

    Jun

  • 06

    Aug

GHDX Genomic Health
$52.13

0.99 (1.94%)

02/21/19
NEED
02/21/19
NO CHANGE
Target $97
NEED
Strong Buy
Genomic Health price target raised to $97 from $86 at Needham
Needham analyst Stephen Unger raised his price target on Genomic Health to $97 and kept his Strong Buy rating after its Q4 results and higher than expected FY19 earnings guidance. The analyst notes that the company's financial model offers "significant operating leverage" that was "clearly demonstrated" in 2018 and sees potential for earnings growth to persist this year thanks to the better than expected testing volumes of its Oncotype breast cancer test product.
05/08/19
ADAM
05/08/19
NO CHANGE
Target $85
ADAM
Buy
Genomic Health price target lowered to $85 from $95 at Canaccord
Canaccord analyst Mark Massaro reiterated a Buy rating on Genomic Health but trimmed his price target to $85 from $95 following the company's "solid" Q1 beat, saying Genomic holds unique qualities as a dominant industry leader in breast cancer recurrence testing. Massaro tells investors in a research note that he believes Genomic Health now appeals to growth, GARP and even value investors.
05/09/19
NEED
05/09/19
NO CHANGE
Target $69
NEED
Strong Buy
Genomic Health price target lowered to $69 from $97 at Needham
Needham analyst Stephen Unger lowered his price target on Genomic Health to $69 but sees the 11.6% stock price decline yesterday in spite of the "strong" Q1 earnings as surprising. The analyst attributes the revised price target to a change in his model to use a "full tax rate" of 18% in his FY20 estimates, also lowering his EPS outlook to $1.60 from $1.86, but keeps his Strong Buy rating on the shares. Unger recommends that investors take advantage of the buying opportunity given the company's solid commercial execution in both U.S. and International markets.
05/30/19
DBAB
05/30/19
NO CHANGE
Target $55
DBAB
Hold
Genomic Health price target lowered to $55 from $80 at Deutsche Bank
Deutsche Bank analyst Dan Leonard lowered his price target for Genomic Health to $55 from $80 to reflect his view that the company's core U.S. invasive breast cancer-testing franchise is maturing, while its efforts to deliver an "encore to its success in breast could remain slow to take root." The analyst keeps a Hold rating on the shares.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
06/20/19
06/20
11:17
06/20/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
06/20/19
06/20
11:16
06/20/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$24.52

0.23 (0.95%)

11:15
06/20/19
06/20
11:15
06/20/19
11:15
Options
KKR put volume heavy and directionally bearish »

Bearish flow noted in KKR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
06/20/19
06/20
11:15
06/20/19
11:15
General news
Treasury announced a $113 B in coupon sales for next week »

Treasury announced a $113…

11:15
06/20/19
06/20
11:15
06/20/19
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

11:15
06/20/19
06/20
11:15
06/20/19
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

BGNE

BeiGene

$124.98

4.98 (4.15%)

11:09
06/20/19
06/20
11:09
06/20/19
11:09
Hot Stocks
BeiGene announces Phase 1b results of zanubrutinib with Gazyva »

BeiGene announced results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

PSNL

Personalis

$0.00

(0.00%)

11:09
06/20/19
06/20
11:09
06/20/19
11:09
Syndicate
Breaking Syndicate news story on Personalis »

Personalis indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

AMRN

Amarin

$19.82

0.4 (2.06%)

11:08
06/20/19
06/20
11:08
06/20/19
11:08
On The Fly
Jefferies sees Amarin stock poised for even more gains »

Seeing the stock's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

STLD

Steel Dynamics

$29.25

-0.45 (-1.52%)

11:05
06/20/19
06/20
11:05
06/20/19
11:05
Options
Steel Dynamics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSON

Misonix

$23.52

(0.00%)

11:04
06/20/19
06/20
11:04
06/20/19
11:04
Hot Stocks
Breaking Hot Stocks news story on Misonix »

Misonix up 39c to $24.17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLNT

Melinta Therapeutics

$5.28

-1.02 (-16.19%)

11:04
06/20/19
06/20
11:04
06/20/19
11:04
Recommendations
Melinta Therapeutics analyst commentary  »

Gabelli fears Melinta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSON

Misonix

$23.52

(0.00%)

11:03
06/20/19
06/20
11:03
06/20/19
11:03
Hot Stocks
SEC tells Misonix investigation concluded, no enforcement action recommended »

Misonix announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSNL

Personalis

$0.00

(0.00%)

10:59
06/20/19
06/20
10:59
06/20/19
10:59
Syndicate
Personalis indicated to open at $28, IPO priced at $17 »

Personalis (PSNL) priced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

AGCO

Agco

$75.20

0.33 (0.44%)

10:57
06/20/19
06/20
10:57
06/20/19
10:57
Conference/Events
Agco management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 24

    Jun

  • 25

    Jun

  • 26

    Jun

WORK

Slack Technologies

$0.00

(0.00%)

10:54
06/20/19
06/20
10:54
06/20/19
10:54
Syndicate
Breaking Syndicate news story on Slack Technologies »

Slack Technologies direct…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDX

VanEck Vectors Gold Miners ETF

$24.79

0.82 (3.42%)

10:50
06/20/19
06/20
10:50
06/20/19
10:50
Options
Recent call buyer in Gold Miners ETF hit the mother lode on Fed stance »

Recent call buyer in Gold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMC

AMC Entertainment

$11.13

-0.39 (-3.39%)

10:45
06/20/19
06/20
10:45
06/20/19
10:45
Options
AMC Entertainment call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

10:45
06/20/19
06/20
10:45
06/20/19
10:45
General news
Breaking General news story  »

3-Month Bill Announcement…

10:45
06/20/19
06/20
10:45
06/20/19
10:45
General news
Breaking General news story  »

6-Month Bill Announcement…

TSN

Tyson Foods

$77.87

0.1 (0.13%)

10:45
06/20/19
06/20
10:45
06/20/19
10:45
Earnings
Tyson Foods sees adjusted EPS growth in 'high single digits' »

In analyst day slides,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

AAPL

Apple

$198.90

1.03 (0.52%)

10:44
06/20/19
06/20
10:44
06/20/19
10:44
Hot Stocks
Apple, in letter to Lighthizer, urges U.S. not to impose additional tariffs »

Apple said in a letter to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBLU

JetBlue

$19.16

0.11 (0.58%)

, EADSY

Airbus

$0.00

(0.00%)

10:43
06/20/19
06/20
10:43
06/20/19
10:43
Periodicals
JetBlue to order 13 A321XLR aircraft from Airbus, Reuters says »

JetBlue (JBLU) will order…

JBLU

JetBlue

$19.16

0.11 (0.58%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCEL

Atreca

$0.00

(0.00%)

10:40
06/20/19
06/20
10:40
06/20/19
10:40
Syndicate
Breaking Syndicate news story on Atreca »

Atreca opens at $19.90,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

DPUKY

Domino's Pizza Group

$0.00

(0.00%)

10:38
06/20/19
06/20
10:38
06/20/19
10:38
Periodicals
Domino's Pizza Group in talks to replace CEO, Sky News reports »

Domino's Pizza Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.